Emyria Ltd · ASX:EMD

Emyria — Shareholder Meeting (November 2026)

9 slides from Emyria's shareholder meeting presentation, Nov 12, 2026

  1. Slide 1: Delivering the new paradigm in mental health care

    ASX : EMD rsonal use only Delivering the new paradigm in mental health care 2026 Annual General Meeting Presentation November 2026 1 Advanced therapies. Compassionate care.

  2. Slide 2: Disclaimer

    Disclaimer This presentation has been prepared by Emyria Limited ACN 625 085 734 (Company or Emyria). This presentation is not a financial product or investment advice or recommendation, offer or invitation by any person or to any person to sell or purchase securities in Emyria in any jurisdiction.

  3. Slide 3: Who are we?

    Brisbane Who are we? Clinics across four states ASX: EMD 5 rsonal use only Building a National network clinics Treating PTSD and treatment- Treatment beds resistant depression 18 Patients treated since commencing service >160 Sydney Perth (x2) Mornington FY26 revenue, up 191% A$4.05m 1) Patients, cl

  4. Slide 4: FY26 revenue up 191% to A$4.05m as the network grew from one clinic to five

    FY26 revenue up 191% to A$4.05m as the network grew from one clinic to five FY26 revenue up 191% to A$4.05m as the network grew from Year ended 30 June 2026 vs prior year one clinic to five Year ended 30 June 2026 vs prior year rsonal use only Revenue Clinics Beds Clinicians trained Authorised Total

  5. Slide 5: Significant momentum in psychedelic drug treatments

    Significant momentum in psychedelic drug treatments Recent macro catalysts provide significant tailwinds for Emyria rsonal use only Emyria is well positioned to leverage this momentum SOURCES 1. https://psychedelics.berkeley.edu/clinical-trials-map

  6. Slide 6: Potential future treatable conditions

    Potential future treatable conditions Significant global research in psychedelic drugs rsonal use only New Treatable Conditions Increase Total Addressable Market SOURCES 1. https://psychedelics.berkeley.edu/clinical-trials-map 6 Advanced therapies. Compassionate care.

  7. Slide 7: Former US Veteran Affairs Secretary Dr David Shulkin has joined to support US opportunities

    Former US Veteran Affairs Secretary Dr David Shulkin has joined to support US opportunities Former US Veteran Affairs Secretary Dr David Shulkin has Strategic Advisor, appointed September 2026 joined to support US opportunities Strategic Advisor, appointed September 2026 rsonal use only As VA Secret

  8. Slide 8: Emyria | Executing strongly

    Emyria (ASX:EMD) | Executing strongly Delivering on commitments to shareholders Recent Achievements rsonal use only • 1st Private Health Insurer Funding Future Drivers: treatments (Medibank) • Additional New Sites Confirmed • Opened 2nd Perth Empax Clinic • 2nd Partner for EGPP • Opened Brisbane Emp

  9. Slide 9: Contact Information

    Contact Information Contact Information rsonal use only Greg Hutchinson ghutchinson@emyria.com Mary-Ann Rennie mrennie@emyria.com Investor / Media Inquiries Visit Our investors@emyria.com Investor Hub

Emyria — Shareholder Meeting (November 2026) on 6ix